Milnacipran improves pain in fibromyalgia patients: Patient E-diary results over 15 weeks in two randomized, double-blind, placebo-controlled trials

被引：0
|
作者：
Mease, Philip [1 ]
Palmer, Robert H. [2 ]
Qu, Peng [2 ]
Gendreau, R. Michael [3 ]
Zablocki, Rong [3 ]
机构：
[1] Seattle Rheurnatol Associates & Swedish Med Ctr, Seattle, WA USA
[2] Forest Res Inst, Jersey City, NJ USA
[3] Cypress Biosci Inc, San Diego, CA USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S383 / S383
页数：1
相关论文
共 50 条
  • [21] Efficacy of Milnacipran Following Long-Term Treatment of Fibromyalgia: Results from a Randomized, Double-Blind, Placebo-Controlled Discontinuation Study
    Clauw, Daniel
    Mease, Philip
    Ma, Yimin
    Baldecchi, Arlene
    Palmer, Robert
    Thacker, Kimberley
    Trugman, Joel
    NEUROLOGY, 2012, 78
  • [22] Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study
    Pickering, Gisele
    Macian, Nicolas
    Delage, Noemie
    Picard, Pascale
    Cardot, Jean-Michel
    Sickout-Arondo, Sophia
    Giron, Fatiha
    Duale, Christian
    Pereira, Bruno
    Marcaillou, Fabienne
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 2485 - 2496
  • [23] A randomized, double-blind, placebo-controlled trial: Paroxetine controlled release in fibromyalgia
    Patkar, AA
    Masand, PS
    Jiang, W
    Krulewicz, S
    Dube, E
    Purcell, C
    McMorran, C
    Peindl, K
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S319 - S320
  • [24] A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUOXETINE IN PATIENTS WITH FIBROMYALGIA
    WOLFE, F
    CATHEY, MA
    HAWLEY, DJ
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S220 - S220
  • [25] Creatine Supplementation in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Alves, Christiano R. R.
    Santiago, Bianca M.
    Lima, Fernanda R.
    Otaduy, Maria C. G.
    Calich, Ana Luisa
    Tritto, Aline C. C.
    de Sa Pinto, Ana Lucia
    Roschel, Hamilton
    Leite, Claudia C.
    Benatti, Fabiana B.
    Bonfa, Eloisa
    Gualano, Bruno
    ARTHRITIS CARE & RESEARCH, 2013, 65 (09) : 1449 - 1459
  • [26] A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Tolerability of Milnacipran 100mg/day in the Management of Fibromyalgia
    Arnold, Lesley
    Gendreau, R. Michael
    Spera, Allan
    Gendreau, Judy
    Wang, Yong
    JOURNAL OF WOMENS HEALTH, 2010, 19 (03) : 605 - 605
  • [27] SODIUM OXYBATE IMPROVES PAIN, FATIGUE, AND SLEEP IN FIBROMYALGIA: RESULTS FROM A 14-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Swick, T. J.
    Alvarez-Horine, S.
    Zheng, Y.
    Rothman, Y.
    Inhaber, N.
    Holman, A.
    Smith, T. R.
    Russell, I
    SLEEP, 2009, 32 : A321 - A321
  • [28] The Efficacy and Tolerability of Milnacipran 100 mg/day Monotherapy for the Management of Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Arnold, Lesley M.
    Gendreau, R. Michael
    Spera, Allan
    Gendreau, Judy
    Wang, Yong
    NEUROLOGY, 2010, 74 (09) : A187 - A187
  • [29] Milnacipran for the Treatment of Fibromyalgia in Adults: A 15-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Clinical Trial
    Clauw, Daniel J.
    Mease, Philip
    Palmer, Robert H.
    Gendreau, R. Michael
    Wang, Yong
    CLINICAL THERAPEUTICS, 2008, 30 (11) : 1988 - 2004
  • [30] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SWITCH STUDY OF THE SAFETY, TOLERABILITY, AND EFFICACY OF MILNACIPRAN IN FIBROMYALGIA PATIENTS WHO INADEQUATELY RESPOND TO DULOXETINE
    Spera, Allan
    Bateman, Lucinda
    Palmer, Robert H.
    Trugman, Joel M.
    Lin, Jennifer
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 : S103 - S104
12345